Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
Abstract:
Methods and systems for diagnosing functional and/or structural abnormalities of the heart preceding heart failure, and for predicting the risk of developing heart failure, in a subject comprising measuring a cardiac troponin in a sample and comparing the measurement to a reference value. Other markers, including GDF15 and IGFBP7 are also measured in some embodiments.
Information query
Patent Agency Ranking
0/0